Spontaneous Coronary Artery Dissection - AntipLatelet Therapy Intensity in Guided coNservative Management (SCAD-ALIGN) Trial
3d agoen
From the article
Conditions : SCAD; ACS (Acute Coronary Syndrome) Interventions : Drug: Acetylsalicylic acid ASA; Drug: ASA plus Clopidogrel Sponsors : Universitätsklinikum Hamburg-Eppendorf; National Institute for Health Research Leicester Biomedical Research Centre, Leicester, UK; Gesellschaft für Therapieforschung mbH; Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK); Cardio-CARE AG, Davos Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Study: Clopidogrel Monotherapy Linked to Lower MACE and Bleeding Risks vs. Aspirin After PCI
A nationwide cohort study published in JACC: Asia found that among stable patients who underwent PCI, transitioning to clopidogrel monothera
acc.org·9d ago
AI-based OCT analysis reveals plaque composition changes after intensive lipid-lowering therapy in non-obstructive coronary lesions: YELLOW III sub-study
This YELLOW III sub-study investigates the impact of intensive lipid-lowering therapy on non-obstructive coronary plaques using AI-based tis
atherosclerosis-journal.com·3d ago
Ondas de choque e balão: hospital brasileiro testa com sucesso novo tratamento para desobstruir placas de gordura nos vasos
Extra Online·2d ago
Study Compares Every-Third-Day vs Daily Low-Dose Aspirin Effects on Thromboxane Inhibition
This study compares the effectiveness of every-third-day versus daily low-dose aspirin therapy on serum thromboxane concentrations in health
pubmed.ncbi.nlm.nih.gov·6mo ago
New drug for cancer patients with ‘limited’ treatment options enters clinical trial
The Independent·3d ago
Four JAK Inhibitors Show Positive Late-Stage Trial Results for Axial Spondyloarthritis Treatment
Positive results from late-stage clinical trials of four JAK inhibitors (filgotinib, gecacitinib, ivarmacitinib, and tofacitinib) for treati
mdsc.pe·17d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.